FDA Approves First-Line Adcetris for Peripheral T-Cell Lymphoma
(MedPage Today) -- Added to chemotherapy, drug delayed disease progression by over 2 years
Source: MedPage Today Public Health - Category: American Health Source Type: news
More News: American Health | Chemotherapy | International Medicine & Public Health | Lymphoma | T-cell Lymphoma